Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Valneva | Paris | Healthcare | Biotechnology & Medical Research | EUR 543.61M | -62x | -0.73 | EUR 3.36 | 7.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Abivax SA | Paris | Healthcare | Biotechnology & Medical Research | EUR 399.13M | -2x | -1.16 | EUR 6.28 | 10% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Eurobio Scientific | Paris | Healthcare | Biotechnology & Medical Research | EUR 261.13M | 43.3x | -1.72 | EUR 26 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.6% Upside | Upgrade to Pro+ | |
Inventiva | Paris | Healthcare | Biotechnology & Medical Research | EUR 220.98M | -1.1x | 0.25 | EUR 2.31 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sensorion SA | Paris | Healthcare | Biotechnology & Medical Research | EUR 190.43M | -6x | -0.13 | EUR 0.63 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genfit | Paris | Healthcare | Biotechnology & Medical Research | EUR 189.49M | 8.5x | 0.05 | EUR 3.79 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nanobiotix | Paris | Healthcare | Biotechnology & Medical Research | EUR 182.98M | -5x | -0.1 | EUR 3.86 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Innate Pharma | Paris | Healthcare | Biotechnology & Medical Research | EUR 158.91M | -4.5x | -0.1 | EUR 1.89 | -3.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cellectis | Paris | Healthcare | Biotechnology & Medical Research | EUR 154.14M | -1.5x | -0.05 | EUR 1.54 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ose Pharma International SA | Paris | Healthcare | Biotechnology & Medical Research | EUR 137.58M | 2.9x | 0.01 | EUR 6.29 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Maat Pharma | Paris | Healthcare | Biotechnology & Medical Research | EUR 104.83M | -4x | 0.1 | EUR 7.40 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Eurofins-Cerep | Paris | Healthcare | Biotechnology & Medical Research | EUR 103.91M | 10x | EUR 20,600 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Transgene | Paris | Healthcare | Biotechnology & Medical Research | EUR 91.60M | -3.1x | -0.12 | EUR 0.69 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Adocia | Paris | Healthcare | Biotechnology & Medical Research | EUR 84.73M | -3.6x | -0.11 | EUR 5.48 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.5% Upside | Upgrade to Pro+ | |
Novacyt | Paris | Healthcare | Biotechnology & Medical Research | EUR 41.98M | -0.9x | 0.02 | EUR 0.60 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Abionyx Pharma SA | Paris | Healthcare | Biotechnology & Medical Research | EUR 41.96M | -11.3x | -0.53 | EUR 1.21 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Gensight Biologics | Paris | Healthcare | Biotechnology & Medical Research | EUR 37.30M | -1x | -0.04 | EUR 0.30 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20% Upside | Upgrade to Pro+ | |
Fermentalg | Paris | Healthcare | Biotechnology & Medical Research | EUR 31.82M | -1.4x | 0.15 | EUR 0.37 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genoway | Paris | Healthcare | Biotechnology & Medical Research | EUR 30.43M | 22.7x | EUR 3.30 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Valbiotis | Paris | Healthcare | Biotechnology & Medical Research | EUR 21.88M | -2.2x | -0.12 | EUR 1.36 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Phaxiam Therapeutics | Paris | Healthcare | Biotechnology & Medical Research | EUR 18.24M | -0.4x | EUR 1.82 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
NFL Biosciences | Paris | Healthcare | Biotechnology & Medical Research | EUR 17.66M | -10.2x | EUR 1.76 | -3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Predilife | Paris | Healthcare | Biotechnology & Medical Research | EUR 14.22M | -3x | 0.18 | EUR 3.80 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Poxel SA | Paris | Healthcare | Biotechnology & Medical Research | EUR 13.93M | -0.6x | -0.01 | EUR 0.26 | -3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Plant Advanced Technologies SA | Paris | Healthcare | Biotechnology & Medical Research | EUR 12.52M | -18.7x | EUR 11.30 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Oncodesign Precision Medicine | Paris | Healthcare | Biotechnology & Medical Research | EUR 10.50M | EUR 0.60 | 3.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
TME Pharma NV | Paris | Healthcare | Biotechnology & Medical Research | EUR 7.06M | -0.2x | -0.01 | EUR 0.08 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Quantum Genomics SA | Paris | Healthcare | Biotechnology & Medical Research | EUR 5.03M | -0.5x | -0.01 | EUR 0.07 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 38.7% Upside | Upgrade to Pro+ | |
Institut Biophytis SAS | Paris | Healthcare | Biotechnology & Medical Research | EUR 4.53M | -0.1x | -0 | EUR 0.29 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Geneuro | Paris | Healthcare | Biotechnology & Medical Research | EUR 4.14M | -0.2x | EUR 0.14 | 2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Theranexus | Paris | Healthcare | Biotechnology & Medical Research | EUR 4.05M | -1.3x | -0.02 | EUR 0.52 | -3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Acticor Biotech | Paris | Healthcare | Biotechnology & Medical Research | EUR 3.92M | -0.2x | -0.01 | EUR 0.25 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Integragen | Paris | Healthcare | Biotechnology & Medical Research | EUR 3.51M | -132.5x | -1.77 | EUR 0.53 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medesis Pharma | Paris | Healthcare | Biotechnology & Medical Research | EUR 2.13M | -0.6x | -0.2 | EUR 0.40 | -5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Coretech 5 | Paris | Healthcare | Biotechnology & Medical Research | EUR 449.13K | -9.6x | EUR 0.03 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Theravet | Paris | Healthcare | Biotechnology & Medical Research | EUR 292.67K | -0.2x | -0.01 | EUR 0.08 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Neovacs | Paris | Healthcare | Biotechnology & Medical Research | EUR 24.53K | -168.4x | EUR 0.17 | -17.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |